AGNPF — Grey Matters Health Inc.

OTC · Health Care · Pharmaceuticals · CIK 1642178 · British Columbia, Canada
Last close
$0.31
Market Cap
$1.68M
52W High
$0.46
52W Low
$0.22
ADV30
497
Next earnings
Grey Matters Health Inc. operates as a clinical stage pharmaceutical development company in Canada, the United States, and Australia. The company focuses on developing the therapeutic drugs in the areas of non-alcoholic steatohepatitis, liver disease, chronic kidney disease, and stroke program. Its pipeline includes repirinast for the treatment of chronic kidney disease; and N,N-Dimethyltryptamine for the treatment of strokes and traumatic brain injuries. The company was formerly known as Algernon Health Inc. and changed its name to Grey Matters Health Inc. in April 2026. Algernon Health Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
May 2026 0 -561,745 -702,029 5,276,358 41,656 3,523,975
Feb 2026 0 -499,628 -499,524 4,948,564 195,349 2,493,598
Nov 2025 0 -597,203 -597,007 4,928,680 210,030 2,443,289
Aug 2025 0 -380,733 -380,500 4,877,474 176,501 2,182,240

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-1,456,957
Investing CF
$155,204
Financing CF
$1,444,102
CapEx
$-19,796
Dividends Paid
Buybacks
EPS Diluted TTM
$-0.64
As of
2026-08-09

Balance + Analyst (yfinance extras)

Retained Earnings
$-31,889,095
Inventory
Receivables
$17,454
ST Investments
EBIT TTM
$-2,167,530
Pretax Income TTM
$-2,179,060
Interest Exp TTM
$12,077
Analysts

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Aug 2025 0 -1,717,794 -1,717,055 4,877,474 2,182,240 -1,157,041
Aug 2024 0 -2,412,042 -502,982 3,944,040 1,775,447 -2,709,577
Aug 2023 0 -5,241,991 -6,781,200 4,193,699 2,719,760 -2,553,008
Aug 2022 0 -6,019,955 -6,054,356 8,140,757 2,516,099 -2,912,741

Peers — same industry

TickerNameMarket CapLastDaily %
SXTC China SXT Pharmaceuticals, Inc. $1.76M $3.30
BPTH BIO-PATH HOLDINGS, INC. $1.77M $0.04
AXIM AXIM BIOTECHNOLOGIES, INC. $1.80M $0.01
MTNB Matinas BioPharma Holdings, Inc. $1.54M $0.24
CDT CDT Equity Inc. $1.85M $2.93

News headlines (Yahoo Finance, 1h cache)

Grey Matters Announces September Opening of its First Brain Dedicated PET Neuroimaging Clinic in the U.S.
2026-08-04 11:00 · Yahoo
Grey Matters Takes Delivery of the First Brain Dedicated PET Scanning System for its Flagship NovaScan Neuroimaging Clinic in Florida
2026-07-06 11:00 · Yahoo
Grey Matters Announces Increase to Private Placement Financing to $1.25 Million and Closing of Offering
2026-06-18 11:00 · Yahoo
Grey Matters Closes First Tranche of $500,000 of its Private Placement Financing
2026-06-05 20:01 · Yahoo
Grey Matters Improves Warrant Terms of Private Placement
2026-05-25 11:00 · Yahoo
Grey Matters Announces Private Placement
2026-04-22 11:00 · Yahoo
Algernon Health Announces Effective Date of Previously Announced Name Change to “Grey Matters Health Inc.” and its 10:1 Share Consolidation
2026-04-15 20:01 · Yahoo
Grey Matters Health appoints veteran radiologist as medical director of Florida NovaScan clinic
2026-08-10 12:57 · Yahoo
Grey Matters Health to open first NovaScan Neuroimaging Clinic in September
2026-08-04 12:37 · Yahoo
Grey Matters Health expands brain imaging services – ICYMI
2026-07-11 13:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.